Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.


Ludwig, H, Delforge, M, Facon, T et al. (29 more authors) (2018) Prevention and management of adverse events of novel agents in multiple myeloma: a consensus of the European Myeloma Network. Leukemia, 32 (7). pp. 1542-1560. ISSN 0887-6924

Cook, G, Zweegman, S, Mateos, M-V et al. (2 more authors) (2018) A question of class: Treatment options for patients with relapsed and/or refractory multiple myeloma. Critical Reviews in Oncology/Hematology, 121. pp. 74-89. ISSN 1040-8428

Moreau, P, van de Donk, NWCJ, San Miguel, J et al. (17 more authors) (2016) Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma (vol 76, pg 853, 2016). Drugs, 76 (9). pp. 989-990. ISSN 0012-6667

This list was generated on Sat Oct 12 22:20:39 2019 BST.